Clinical Trials Browser

Phase 2 × Interventional × NUC-1031 × Clear all

NCT03146663 2021-02-21

NUC-1031 in Patients With Platinum-Resistant Ovarian Cancer

Phase 2 Terminated

53 enrolled 19 charts

Ovarian Diseases, Ovarian Neoplasms